Policy & Geopolitics
Aquestive's Anaphylm FDA Rejection Validates Core Science—Stock Surges 40% After Hours
Feb 2
You're signed outSign in or to get full access.
Aquestive Therapeutics (AQST) Earnings Call Transcripts
Browse quarterly earnings call transcripts for Aquestive Therapeutics.
Q3 2025
Nov 6, 2025
Q2 2025
Aug 12, 2025
Q1 2025
May 13, 2025
Q4 2024
Mar 6, 2025
Q3 2024
Nov 5, 2024
Q2 2024
Aug 7, 2024
Q1 2024
May 8, 2024
Q4 2023
Mar 6, 2024
Q3 2023
Nov 7, 2023
Q2 2023
Aug 8, 2023
Q1 2023
May 3, 2023
Q1 2022
May 4, 2022